Role of Vitamin D in Wnt Pathway Activation for Colonic Epithelial Cell Differentiation
Overview
Affiliations
Objectives: Inflammatory bowel disease (IBD) is a medical condition that represents a pathological form of inflammation, causing damage to the colonic mucosa. Adjunctive vitamin D therapy may activate the Wnt/β-catenin pathway that results in cell differentiation and proliferation via stem cell signalling. This study aims to evaluate the effect of vitamin D on β-catenin and cytokeratin 20 (KRT20) as markers of Wnt pathway activation for colonic cell repair.
Methods: For the experiment, we used 30 musculus mice strains of BALB/c, which were categorised into five groups; the control group (K-) and four other groups, where colitis was induced by dextran sulphate sodium (DSS) for seven days. On the seventh day, the remaining three groups were administered vitamin D with an initial dose of 0.2 μg/25.0 g, 0.4 μg/25.0 g and 0.6 μg/25.0 g until day 14. An objective index of disease activity and a histological score were required as markers of inflammation to evaluate the results of the clinical trials.
Results: β-catenin and KRT20 showed a significant increase in the proliferation index of vitamin D at a dose of 0.6 μg/25.0 g (91.50 ± 4.09 and 48.75 ± 2.28, respectively; < 0.05) compared to the colitis group.
Conclusions: This study demonstrates that vitamin D could be used as an induction agent of Wnt activation for healing colonic mucosa via multipotent stem cells.
Ho J, Puoplo N, Pokharel N, Hirdaramani A, Hanyaloglu A, Cheng C Front Genet. 2024; 15:1349717.
PMID: 39280096 PMC: 11393785. DOI: 10.3389/fgene.2024.1349717.
Muneeb M, Mansou S, Saleh S, Mohammed R PLoS One. 2022; 17(11):e0277457.
PMID: 36374861 PMC: 9662739. DOI: 10.1371/journal.pone.0277457.
Efficacy and Safety of Vitamin D Adjuvant Therapy for Ulcerative Colitis: A Meta-Analysis.
Guo X, Liu C, Huang Y Comput Math Methods Med. 2022; 2022:6836942.
PMID: 35912148 PMC: 9328974. DOI: 10.1155/2022/6836942.